Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-02-28
1997-07-08
Elliott, George C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 536 221, 536 231, 536 243, 536 245, A61K 4800, C12Q 168, C07H 2102, C07H 2104
Patent
active
056461267
ABSTRACT:
Oligonucleotides having approximately 8 to 18 nucleotide units and a 3'-tail which includes asteroid structure attached to the 3'-end through the A ring of the steroid skeleton and which form substantially stable duplexes at physiological temperature, have selective cytotoxic activity against certain tumor cell lines.
REFERENCES:
Chu et al, "The stability of differenr forms of double-stranded decoy DNA in serum and nuclear extracts", Nucleic Acids Res. 20(21):5857-5858 1992.
Gryaznov et al, "Modulation of oligonucleotide duplex and triplex stability via hydrophobic interactions", Nucleic Acids Res. 21(25):5909-5915 1993.
Ma et al, "Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double stranded cyclic HIV-1 TAR RNA analogs with high Tat binding affinity", Nucleic Acids Res. 21(11):2585-2589 1993.
Ma et al, "Design and synthesis of RNA miniduplexes via a synthetic linker approach", Biochemistry 32:1751-1758 1993.
Bielinska et al, "Regulation of gene expression with double-stranded phosphorothioate oligonucleotides", Science 250:997-1000 Nov. 1990.
MacKellar et al, "Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups", Nucleic Acids Res. 20(13):3411-3417 1992.
Zhou et al, "Discovery of short, 3' cholesterol modified DNA duplexes with unique antittumor cell activity", Cancer Res. 54:5783-5787 Nov. 1994.
Stanfield et al., "Synthesis of protected amino alcohols: a comparative study", J. Org. Chem., 46:4799 (1981).
Gamper, H. B. et al., "Facile preparation and exonuclease stability of 3' modified oligodeoxynucleotides", Nucleic Acids Res., 21, 145-150 (1993).
Reed, M. W. et al., "Arcidine and cholesterol-derivatized solid supports for improved synthesis of 3'-modified oligonucleotides", Bioconjugate Chem., 2, 217-225 (1993).
Atkinson, T. and Michael S., "Solid-phase synthesis of oligodeoxyribonecleotides by the phosphitetriester method", Oligonucleotide Synthesis: A Practical Approach, M. J. Gait, ed., IRL Press, pp. 35-81 (1984).
Cheng Yung-Chi
Lukhtanov Eugeny A.
Meyer, Jr. Rich B.
Pai Balakrishna S.
Reed Michael W.
Elliott George C.
Epoch Pharmaceuticals
Fredman Jeffrey
Yale University
LandOfFree
Sterol modified oligonucleotide duplexes having anticancer activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sterol modified oligonucleotide duplexes having anticancer activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sterol modified oligonucleotide duplexes having anticancer activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408911